Erelzi 25 mg/0.5 ml

Erelzi 25 mg/0.5 ml is a medicine authorised by Swissmedic under authorisation number 66175. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 May 2018 and the authorisation is valid without a time limit. ATC code L04AB01 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 66175
  • ATC L04AB01
  • Biotechnological medicines
Authorisation data
Authorisation number66175
NameErelzi 25 mg/0.5 ml
Full nameErelzi 25 mg/0.5 ml, Injektionslösung in einer Fertigspritze
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AB01
First authorisation18 May 2018
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Erelzi 25 mg/0.5 ml, Injektionslösung in einer FertigspritzeB18 May 2018
2Erelzi 50 mg/1 ml, Injektionslösung in einer FertigspritzeB18 May 2018

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)L04AB0107.15.0.B
22Fertigspritze(n)L04AB0107.15.0.B
34Fertigspritze(n)L04AB0107.15.0.B
412Fertigspritze(n)L04AB0107.15.0.B
51Fertigspritze(n)L04AB0107.15.0.B
62Fertigspritze(n)L04AB0107.15.0.B
74Fertigspritze(n)L04AB0107.15.0.B
812Fertigspritze(n)L04AB0107.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Erelzi 25 mg/0.5 ml authorised in Switzerland?

Yes. Erelzi 25 mg/0.5 ml is authorised by Swissmedic under authorisation number 66175, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Erelzi 25 mg/0.5 ml have?

Erelzi 25 mg/0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Erelzi 25 mg/0.5 ml?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com